Risk of intracranial meningioma with three potent progestogens: A population‐based case–control study
L Hoisnard, M Laanani, T Passeri… - European Journal of …, 2022 - Wiley Online Library
Background and purpose A dose‐dependent association between the use of cyproterone
acetate (CPA) and intracranial meningioma has been identified but data for other potent …
acetate (CPA) and intracranial meningioma has been identified but data for other potent …
[HTML][HTML] Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section
Introduction The evolution of cavernous sinus meningiomas (CSMs) might be unpredictable
and the efficacy of their treatments is challenging due to their indolent evolution, variations …
and the efficacy of their treatments is challenging due to their indolent evolution, variations …
Meningioma in patients exposed to progestin drugs: results from a real-life screening program
Purpose To report the results of systematic meningioma screening program implemented by
French authorities in patients exposed to progestin therapies (cyproterone (CPA) …
French authorities in patients exposed to progestin therapies (cyproterone (CPA) …
[PDF][PDF] Brain and Spine
Introduction: The evolution of cavernous sinus meningiomas (CSMs) might be unpredictable
and the efficacy of their treatments is challenging due to their indolent evolution, variations …
and the efficacy of their treatments is challenging due to their indolent evolution, variations …